undamentalytics Newsletter

Broadwood Capital Inc: insider trades

Director, 10% owner at 3 companies we cover. 28 open-market purchases and 6 sales not made under a pre-set plan, reported from September 10, 2010 to April 20, 2026.

Would copying Broadwood Capital Inc’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 17 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on November 7, 2012 into $6,379 by November 2, 2026, −3.2% a year. The copy held shares only 54% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $41,216, +10.7% a year (the S&P 500 held throughout made $68,832, +14.8% a year). Beta against the index was 0.41. Twelve months after each report, the average purchase was −7.0% against the S&P 500 (median −11.0%), and 35% beat it. Measured from the trade date, the insider’s own timing, the average was −3.1%. After their sales, the shares moved −48.3% against the index over 12 months on average (a negative figure means selling was the right call); 100% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$20.0k$40.0k$60.0k 20122014201620182020202220242026 $68.8k$41.2k$6.4k
Copying Broadwood Capital IncS&P 500, same days investedS&P 500, held throughout $10,000 copying Broadwood Capital Inc’s open-market purchases from November 7, 2012, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
−3.2%
S&P 500, same days invested
+10.7% (held throughout +14.8%)
Time in shares
54%
Sharpe ratio (S&P 500)
0.11 (0.80)
Biggest drop (S&P 500)
−90% (−34%)
Market sensitivity (beta)
0.41
Purchases copied
18

Trade by trade

Broadwood Capital Inc: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 18 −3.2% −8.9% 33% 8 −0.48 0.65 No reliable evidence
Purchases, 6 months after the report 18 +10.1% +8.3% 61% 8 0.55 0.60 No reliable evidence
Purchases, 12 months after the report 17 −7.0% −11.0% 35% 7 −0.37 0.73 No reliable evidence
Purchases, 12 months after the trade 17 −3.1% −12.5% 35% 7 −0.19 0.85 No reliable evidence
Sales, 3 months after the report 6 −3.6% −11.9% 67% 1 — — Not enough years
Sales, 12 months after the report 6 −48.3% −49.0% 100% 1 — — Not enough years
Sales, 12 months after the trade 6 −48.9% −50.0% 100% 1 — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Staar Surgical Co STAA —186September 10, 2010March 13, 2026
Lineage Cell Therapeutics, Inc. LCTX —50December 30, 2013January 28, 2025
Insight Molecular Diagnostics Inc. IMDX —50March 30, 2018April 20, 2026

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
April 20, 2026April 16, 2026 IMDX Purchase $653,181 not yetnot yetnot yet
March 13, 2026March 11, 2026 STAA Purchase $12,269,410 +43.8%not yetnot yet
March 25, 2025March 21, 2025 STAA Purchase $2,414,698 −12.1%−11.0%−10.1%
March 20, 2025March 18, 2025 STAA Purchase $3,585,937 −12.6%−10.1%−23.4%
March 6, 2025March 4, 2025 STAA Purchase $481,911 −6.9%−25.0%−14.9%
March 3, 2025February 27, 2025 STAA Purchase $11,274,619 −7.1%−14.9%−11.0%
January 28, 2025January 27, 2025 LCTX Purchase $6,000,000 not yetnot yetnot yet
December 18, 2024December 16, 2024 STAA Purchase $1,947,511 −28.9%−23.4%−12.5%
October 4, 2024October 2, 2024 IMDX Purchase $3,880,250 not yetnot yetnot yet
January 10, 2024January 8, 2024 STAA Purchase $109,579 +43.5%−58.1%−53.0%
November 30, 2023November 28, 2023 STAA Purchase $13,704,269 −10.0%−53.0%−45.3%
October 6, 2023October 4, 2023 STAA Purchase $7,762,560 −26.1%−57.5%−46.3%
September 21, 2023September 19, 2023 STAA Purchase $11,688,980 −28.5%−52.6%−53.9%
June 28, 2021June 24, 2021 STAA Sale $35,650,796 −17.1%−42.0%−44.8%
June 21, 2021June 16, 2021 STAA Sale $16,168,382 −8.4%−44.7%−47.4%
April 26, 2021April 22, 2021 STAA Sale $15,753,765 −15.3%−56.7%−57.2%
February 12, 2021February 10, 2021 STAA Sale $4,659,609 −16.2%−56.3%−54.8%
February 9, 2021February 5, 2021 IMDX Purchase $2,700,000 −39.8%−89.8%−89.1%
February 4, 2021February 2, 2021 STAA Sale $6,755,866 +9.6%−53.3%−52.6%
January 12, 2021January 12, 2021 STAA Sale $5,356,800 +25.7%−36.5%−36.2%
August 15, 2019August 13, 2019 LCTX Purchase $24,030 not yetnot yetnot yet
February 12, 2019February 8, 2019 IMDX Purchase $1,999,999 not yetnot yetnot yet
March 30, 2018March 28, 2018 IMDX Purchase $5,000,000 not yetnot yetnot yet
May 19, 2016May 17, 2016 STAA Purchase $48,707 +63.1%+58.9%+65.7%
February 16, 2016February 11, 2016 STAA Purchase $3,329,937 −26.3%+28.4%+28.5%
January 15, 2016January 13, 2016 STAA Purchase $913,544 +2.7%+23.6%+27.7%
January 12, 2016January 8, 2016 STAA Purchase $591,152 +2.4%+27.7%+37.1%
January 7, 2016January 5, 2016 STAA Purchase $1,857,119 +8.5%+37.1%+37.7%
November 4, 2014October 31, 2014 STAA Purchase $2,394,257 −16.2%−9.8%−17.7%
May 16, 2014May 16, 2014 LCTX Purchase $735,000 not yetnot yetnot yet
May 5, 2014May 1, 2014 LCTX Purchase $5,040,000 not yetnot yetnot yet
December 30, 2013December 26, 2013 LCTX Purchase $1,052,148 not yetnot yetnot yet
November 6, 2012November 2, 2012 STAA Purchase $112,860 −7.7%+111.2%+127.6%
September 10, 2010September 8, 2010 STAA Purchase $124,985 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Broadwood Capital Inc traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.